Considerable added benefit of ipilimumab in advanced melanoma, study suggests
Friday, November 9, 2012 - 17:00
in Health & Medicine
The humanized antibody ipilimumab has been approved since August 2011 and is used for the treatment of adult patients with advanced melanoma. The drug offers major advantages with respect to survival, but is accompanied by major side effects. The overall conclusion is that ipilimumab offers considerable added benefit.